BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

591 related articles for article (PubMed ID: 11363187)

  • 1. d4T plus ddI antiviral results.
    AIDS Treat News; 1996 Feb; (no 241):3. PubMed ID: 11363187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ddI plus d4T.
    James JS
    AIDS Treat News; 1996 Sep; (No 254):4. PubMed ID: 11363818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety profile and antiviral activity of the combination of stavudine, didanosine, and nelfinavir in patients with HIV infection.
    Elion R; Kaul S; Knupp C; Adler M; Cross AP; Dunkle LM; Kelleher T
    Clin Ther; 1999 Nov; 21(11):1853-63. PubMed ID: 10890257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, dose-finding study with didanosine plus stavudine versus didanosine alone in antiviral-naive, HIV-infected Thai patients.
    Ruxrungtham K; Kroon ED; Ungsedhapand C; Teeratakulpisarn S; Ubolyam S; Buranapraditkun S; van Leeuwen R; Weverling GJ; Kunanusont C; Lange JM; Cooper DA; Phanuphak P
    AIDS; 2000 Jul; 14(10):1375-82. PubMed ID: 10930152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining d4T/ddI looks promising.
    Posit Aware; 1996; 7(1):7. PubMed ID: 11363129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo antagonism with zidovudine plus stavudine combination therapy.
    Havlir DV; Tierney C; Friedland GH; Pollard RB; Smeaton L; Sommadossi JP; Fox L; Kessler H; Fife KH; Richman DD
    J Infect Dis; 2000 Jul; 182(1):321-5. PubMed ID: 10882616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. d4T plus ddI: warning for pregnant women.
    AIDS Treat News; 2001 Jan; (358):8. PubMed ID: 12173560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. d4T and ddI shown to be safe and effective.
    AIDS Patient Care STDS; 1997 Aug; 11(4):287. PubMed ID: 11361844
    [No Abstract]   [Full Text] [Related]  

  • 9. New questions about an old combination--ddI + d4T.
    Proj Inf Perspect; 2003 Jan; (35):13-4. PubMed ID: 12647675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dethroning AZT.
    Gilden D; Falkenberg J; Torres G
    GMHC Treat Issues; 1997 Feb; 11(2):10-3. PubMed ID: 11364106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severity of the toxicity associated with combinations that include didanosine plus stavudine in HIV-infected experienced patients.
    Hernández B; Moreno S; Pérez-Elías MJ; Casado JL; Dronda F; Moreno A; Antela A
    J Acquir Immune Defic Syndr; 2006 Dec; 43(5):556-9. PubMed ID: 17057611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxyurea for HIV infection.
    Zachary KC; Davis B
    AIDS Clin Care; 1998 Apr; 10(4):25-6, 32. PubMed ID: 11365149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleoside combinations for antiretroviral therapy: efficacy of stavudine in combination with either didanosine or lamivudine.
    Fisher M
    AIDS; 1998; 12 Suppl 3():S9-16. PubMed ID: 15168718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of stavudine plus didanosine in asymptomatic HIV-infected children with plasma HIV RNA below 50,000 copies per milliliter.
    de Mendoza C; Ramos JT; Ciria L; Fortuny C; García FJ; de José MI; Asensi F; Soriano V
    HIV Clin Trials; 2002; 3(1):9-16. PubMed ID: 11819180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Didanosine plus stavudine with or without hydroxyurea in HIV-1-infected patients: 1 year follow-up. Swiss HIV Cohort Study.
    Rutschmann OT; Opravil M; Iten A; Malinverni R; Vernazza PL; Bucher H; Bernasconi E; Perrin LH; Yerly S; Hirschel B
    Antivir Ther; 1998; 3 Suppl 4():65-7. PubMed ID: 10723515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug combo safe for HIV-infected children.
    NIAID AIDS Agenda; 1996 Sep; ():7. PubMed ID: 11363927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial to investigate the recycling of stavudine and didanosine with and without hydroxyurea in salvage therapy (RESTART).
    Stebbing J; Nelson M; Orkin C; Mandalia S; Bower M; Pozniak A; Gazzard B
    J Antimicrob Chemother; 2004 Mar; 53(3):501-5. PubMed ID: 14762056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study of combination therapy with indinavir, stavudine (d4T), and didanosine (ddI) in children infected with the human immunodeficiency virus.
    Kline MW; Fletcher CV; Harris AT; Evans KD; Brundage RC; Remmel RP; Calles NR; Kirkpatrick SB; Simon C
    J Pediatr; 1998 Mar; 132(3 Pt 1):543-6. PubMed ID: 9544920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tenofovir drug interactions: ddI and d4T.
    TreatmentUpdate; 2003; 15(2):7. PubMed ID: 12693363
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiviral roundup.
    Smart T; Torres G
    GMHC Treat Issues; 1996 Aug; 10(8):6-7. PubMed ID: 11363720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.